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We focused on the effects of BPC 157 on acute unilateral renal ischemia in rats, subsequent severe 
portal (PV) and inferior vena cava (IVC) hypertension and thrombosis, abdominal aorta (AA) 
hypotension, peaked or inverted P waves and gastrointestinal lesions. Medication (/kg) (BPC 157 (10 
μg)(treated group) or saline (5 ml)(control group)) was applied as an abdominal bath immediately after 
the right renal artery was ligated. 10min, 1h, and 24h after ligation electrocardiography, USB 
microcamera recording, intravascular cannulation, and thrombi extraction was performed. Control rats 
exhibited PV and IVC hypertension, aortic hypotension (mmHg) (10min: 32±2 PV, 24±4 IVC, 75±2 
AA; 1h: 43±4 PV, 46±3 IVC, 73±4 AA; 24h: 30±2 PV, 34±1 IVC, 86±3 AA) and thrombosis (thrombus 
weight, mg) (10min: 1.3±0.3 IVC, 3.5±0.4 PV; 1h: 15.1±0.5 IVC, 5.4±0.2 PV; 24h: 16.3±1.5 IVC, 
6.1±0.9 PV). Treated group showed improved pressure values (10min: 4±1 PV, 8±1 IVC, 84±3 AA; 
1h: 18±2 PV, 6±1 IVC, 92±3 AA; 24h: 5±1 PV, 10±1 IVC, 97±2 AA) and milder thrombosis (10min: 
no thrombi; 1h: 7.7±0.3 IVC, 2.3±0.2 PV; 24h: 11.6±0.5 IVC, 3.2±0.2 PV). Control rats exhibited 
peaked (10 min, 1h) or inverted (24h) P waves, gastric and intestinal lesions (24h) and complete renal 
infarction (24h), whereas the treated rats exhibited no P wave abnormalities, significantly mitigated 
gastrointestinal lesions (24h) and only partial renal infarction (24h). BPC 157 therapy reduces the 
severity of renal ischemia injury, counteracts hemodynamic disturbances, P wave abnormalities and 
gastrointestinal lesions that follow. 
 
 
  
